WuXi XDC and LegoChem sign MoD to make more ADCs accessible to patients
XDC will provide a full range of development and manufacturing services in one centralised region
China's WuXi XDC, a recently established CDMO, and South Korea-based LegoChem Biosciences, have signed a Memorandum of Understanding (MoU) to form a strategic partnership regarding the development and manufacturing of antibody-drug conjugates (ADCs).
The partnership grants LegoChem access to XDC's integrated services in monoclonal antibody (mAb), linker, payload, analytical and formulation development, as well as ADC drug substance and drug product development and manufacturing.
Last month, WuXi Biologics and WuXi STA (a subsidiary of WuXi AppTec) formed the joint venture CDMO to provide end-to-end contract development and manufacturing of bioconjugates including ADCs.
According to Dr Chris Chen, CEO of WuXi Biologics and Chairman of WuXi XDC, combining the capabilities and capabilities of both companies, XDC will provide a "one-stop service" for global partners; thus expediting development and lowering costs.
XDC's CEO Dr Jimmy Li said the company has witnessed increasing outsourced demand for ADCs as more ADC programs advance towards clinical trials and commercial production.
Related News
-
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Executive order to elevate US pharma manufacturing signed by Trump
On Monday, May 5, US President Trump signed an executive order to reduce regulatory barriers for domestic US pharmaceutical manufacturing, including key ingredients and materials for manufacturing prescription drugs.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News China import tax fine could cost AstraZeneca up to US$8 million
British-Swedish drugmaker AstraZeneca could find itself facing fines of up to US$8million in China due to suspected unpaid import taxes on breast cancer drug Enhertu.
-
News Women in Pharma: Building from the ground up together
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pharmaceutical Packaging Market Prospects – Innovations in Packaging and Drug Delivery
Download the Pharmaceutical Packaging Market Prospects Trend Report to explore the full report and delve into the evolving opportunities in pharmaceutical packaging and drug delivery. -
News A Day at CPHI Americas 2025 – What to Expect
CPHI returns to Philadelphia from May 20-22, 2025 under a new name – CPHI Americas. As we aim to bring together pharma professionals for 3 days of innovation and collaboration, CPHI Americas 2025 hopes to recognise the growing influence of the Am... -
News Novartis to invest US$23 billion in US facilities amid tariff threats
Swiss pharmaceutical giant Novartis has announced its intention to invest up to US$23 billion in building and expanding ten pharmaceutical facilities in the US as drugmakers scramble to respond to potential drug import and manufacturing tariffs declare...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance